Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Cash flows from operating activities:
Net income (loss)	$ 4,140,104	$ (57,342)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
General and administrative expenses paid by related party	235,268
Interest income on investments held in the Trust Account	(5,465,011)
Change in fair value of forward sale securities	569,799
Changes in operating assets and liabilities:
Deferred offering costs	217,609	(116,665)
Prepaid expenses	249,937	2,740
Receivable from related party	(375)
Other assets	(50,193)
Accrued expenses	155,440	86,687
Net cash provided by (used in) operating activities	52,578	(84,580)
Cash flows from investing activities:
Cash deposited in the Trust Account	(200,000,000)
Net cash used in investing activities	(200,000,000)
Cash flows from financing activities:
Proceeds received from initial public offering	200,000,000
Proceeds received from private placement	5,000,000
Offering costs paid	(4,298,137)
Deferred offering costs paid by related party	(231,756)
Proceeds from Notes payable – related party	330,261	84,580
Payment on Notes payable – related party	(134,240)
Payment on Payable to related party	(693,706)
Net cash provided by financing activities	199,972,422	84,580
Net change in Cash	25,000
Cash – beginning of the period
Cash – end of the period	25,000
Supplemental disclosure of non-cash activities:
Deferred offering costs included in Accrued expenses		$ 86,165